Related Experiment Video
Updated: May 16, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Epidemiological and economical burden of cholestatic liver disease
Bregje Mol1,2, Ellen Werner3, Emma L Culver4
1Department of Gastroenterology and Hepatology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Insights
Primary sclerosing cholangitis, primary biliary cholangitis, and IgG4-related cholangitis are increasingly important liver diseases. Understanding their epidemiology and patient impact is crucial as they rise in prevalence.
Area of Science:
- Hepatology and Gastroenterology
- Rare Diseases
- Immunology
Background:
- Cholestatic liver diseases, including primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), and IgG4-related cholangitis (IgG4-AC), are gaining clinical significance.
- Their incidence is rising, contrasting with declining viral hepatitis rates, making them a growing focus in hepatology.
- These conditions are now a leading reason for liver transplantation in Western nations.
Purpose of the Study:
- To offer a comprehensive review of the epidemiology of PSC, PBC, and IgG4-AC.
- To examine the impact of these cholestatic liver diseases on health-related quality of life.
- To assess the economic burden associated with PSC, PBC, and IgG4-AC.
Main Methods:
- Systematic literature review of epidemiological data.
- Analysis of studies reporting on quality of life in patients with PSC, PBC, and IgG4-AC.
- Review of economic evaluations and cost-of-illness studies.
Main Results:
- Cholestatic liver diseases represent a growing public health concern with increasing prevalence.
- Patients with PSC, PBC, and IgG4-AC experience significant decrements in quality of life.
- These diseases impose a substantial economic burden on healthcare systems and society.
Conclusions:
- PSC, PBC, and IgG4-AC require greater attention due to their rising incidence and impact.
- Further research into effective management strategies and patient support is warranted.
- Addressing the quality of life and economic consequences is essential for comprehensive patient care.
Abstract:
The main cholestatic liver diseases comprise primary sclerosing cholangitis, primary biliary cholangitis, and IgG4-related cholangitis. Despite being classified as rare diseases, these are becoming gradually more important in the field of hepatology since their incidence is slowly rising while the viral hepatitis burden is declining. Cholestatic liver diseases now rank among the 3 most frequent indications for liver transplantation in many Western countries. An accurate understanding of the epidemiology and burden of disease on both the individual and society of cholestatic diseases is of great importance. This review aims to provide a comprehensive overview of the current literature on the epidemiology, health-related quality of life, and economic burden of primary sclerosing cholangitis, primary biliary cholangitis, and IgG4-related cholangitis.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Hepatic Drug Excretion: Influencing Factors
Gross Anatomy of the Liver
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...

